false
0002019505
0002019505
2025-09-24
2025-09-24
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 OR 15(d) of The Securities
Exchange Act of 1934
September 24, 2025
Date of Report (Date of earliest event reported)
Health In Tech, Inc.
(Exact name of registrant as specified in its charter)
| Nevada |
|
001-42449 |
|
87-3545722 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
701 S. Colorado Ave, Suite 1
Stuart, FL |
|
34994 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (888) 373-0333
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Class A Common Stock, $0.001 par value per share |
|
HIT |
|
The Nasdaq Stock Market LLC
(Nasdaq Capital Market) |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 24, 2025, the
Compensation Committee of the Board of Directors of Health In Tech, Inc., a Nevada corporation (the “Company”), approved the
grant of restricted stock awards (the “RSAs”) to Tim Johnson, the Company’s Chief Executive Officer, and Linlin (Julia)
Qian, the Company’s Chief Financial Officer. The Company granted the RSAs to Mr. Johnson and Ms. Qian in connection with services
these named executive officers are providing to the Company to develop a new initiative, which is referred to in this Current Report on
Form 8-K as the “Initiative”. Mr. Johnson received a grant of 80,000 shares of restricted stock in connection with the Initiative
and Ms. Qian received a grant of 80,000 shares of restricted stock in connection with the Initiative. One third (1/3) of the total number
of shares of restricted stock granted to each recipient shall vest in equal monthly installments over a twelve (12) month period commencing
on the date a letter of intent or memorandum of understanding is signed, one third (1/3) of the shares shall vest in equal monthly installments
over a twelve (12) month period commencing on the date the Initiative enters proof-of-concept or beta launch, and the remaining one third
(1/3) shall vest in equal monthly installments over a twelve (12) month period commencing on the date of the full commercial launch of
the Initiative. The RSAs were granted pursuant to the Health In Tech, Inc. Equity Incentive Plan and are subject to the terms and conditions
set forth in the Restricted Stock Award Agreements previously approved by the Compensation Committee.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 26, 2025
HEALTH IN TECH, INC.
| By: |
/s/ Tim Johnson |
|
| Name: |
Tim Johnson |
|
| Title: |
Chief Executive Officer |
|
